We are live on ! Find out more
SP

SIH Partners Portfolio holdings

AUM $7.58B
1-Year Est. Return 5.28%
This Fund
S&P 500
This Quarter Est. Return
+1.62%
1 Year Est. Return
+5.28%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.69B
AUM Growth
-$263M
Cap. Flow
-$386M
Cap. Flow %
-14.36%
Top 10 Hldgs %
65.93%
Holding
325
New
55
Increased
42
Reduced
42
Closed
171

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$127M
2
JD icon
JD.com
JD
+$62.9M
3
AMRZ
Amrize Ltd
AMRZ
+$50.6M
4
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$45M
5
LI icon
Li Auto
LI
+$25M

Top Sells

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$127M
2
UBS icon
UBS Group
UBS
+$114M
3
STLA icon
Stellantis
STLA
+$55.8M
4
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$28.1M
5
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$24.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 20.42%
2 Materials 3.76%
3 Communication Services 3.25%
4 Technology 1.63%
5 Healthcare 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QSI icon
276
Quantum-Si Incorporated
QSI
$168M
– –
-10,624
Closed -$12.7K
RARE icon
277
Ultragenyx Pharmaceutical
RARE
$2.65B
– –
-5,738
Closed -$208K
REGN icon
278
Regeneron Pharmaceuticals
REGN
$68.8B
– –
-7,750
Closed -$4.92M
RNAM
279
DELISTED
Avidity Biosciences
RNAM
– –
-7,533
Closed -$222K
ROIV icon
280
Roivant Sciences
ROIV
$25.2B
– –
-44,403
Closed -$448K
RPRX icon
281
Royalty Pharma
RPRX
$26.1B
– –
-26,881
Closed -$837K
RVMD icon
282
Revolution Medicines
RVMD
$40.2B
– –
-11,702
Closed -$414K
RXRX icon
283
Recursion Pharmaceuticals
RXRX
$1.57B
– –
-51,202
Closed -$271K
RYTM icon
284
Rhythm Pharmaceuticals
RYTM
$7B
– –
-3,980
Closed -$211K
SANA icon
285
Sana Biotechnology
SANA
$885M
– –
-13,427
Closed -$22.6K
SMMT icon
286
Summit Therapeutics
SMMT
$10.9B
– –
-46,492
Closed -$897K
SRPT icon
287
Sarepta Therapeutics
SRPT
$1.66B
– –
-5,867
Closed -$374K
SU icon
288
Suncor Energy
SU
$77.7B
– –
-7,099
Closed -$275K
SVRA icon
289
Savara
SVRA
$1.13B
– –
-10,847
Closed -$30K
SWTX
290
DELISTED
SpringWorks Therapeutics
SWTX
– –
-4,628
Closed -$204K
SYK icon
291
Stryker
SYK
$127B
– –
-6,238
Closed -$2.32M
TAL icon
292
TAL Education Group
TAL
$5.71B
– –
-162,100
Closed -$2.14M
TD icon
293
Toronto Dominion Bank
TD
$198B
– –
-8,554
Closed -$513K
TME icon
294
Tencent Music
TME
$14.5B
– –
-180,300
Closed -$2.6M
TMO icon
295
Thermo Fisher Scientific
TMO
$211B
– –
-3,819
Closed -$1.9M
TSHA icon
296
Taysha Gene Therapies
TSHA
$1.59B
– –
-12,173
Closed -$16.9K
TWST icon
297
Twist Bioscience
TWST
$5.62B
– –
-8,311
Closed -$326K
TXG icon
298
10x Genomics
TXG
$5.87B
– –
-13,401
Closed -$117K
UEC icon
299
Uranium Energy
UEC
$4.71B
– –
-15,840
Closed -$75.7K
UMC icon
300
CALL
United Microelectronic
UMC
$48.9B
– –
-38,500
Closed -$275K
9 10 11
12
13

Similar funds

OPERF
Oregon Public Employees Retirement Fund Tigard, Oregon $7.58B AUM 27.19% 1-Year Est. Return
AIM
Adapt Investment Managers Geneva, Switzerland $7.56B AUM 29.66% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return

SIH Partners's Q2 2025 Portfolio in Review

As of Q2 2025, SIH Partners held 325 positions worth $2.69B, down 8.9% from $2.95B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

SIH Partners withdrew a net $386M in Q2 2025, closing 171 positions and reducing 42 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $28.1M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 14% a quarter earlier, followed by Materials and Communication Services.

Against the trend, SIH Partners opened a new position in Amrize Ltd worth $49.7M.

  • SIH Partners's largest Q2 2025 buy was Amrize Ltd: 1,003,159 shares worth $49.7M.
  • SIH Partners added most to Alibaba in Q2 2025, an estimated $127M increase.
  • SIH Partners's biggest Q2 2025 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $127M.
  • SIH Partners fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q2 2025, selling an estimated $28.1M.
  • SIH Partners's ten largest holdings make up 66% of its $2.69B portfolio in Q2 2025.
  • SIH Partners opened 55 new positions and closed 171 in Q2 2025.
  • SIH Partners's portfolio value fell 8.9% quarter-over-quarter to $2.69B.

Based on SIH Partners's 13F filing for Q2 2025, filed 14 Aug 2025.